Evaxion Biotech Files Routine 6-K Report
Ticker: EVAX · Form: 6-K · Filed: Mar 25, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion Biotech A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K
TL;DR
Evaxion Biotech filed a 6-K, just routine paperwork, no big news.
AI Summary
Evaxion Biotech A/S filed a Form 6-K on March 25, 2025, reporting for the month of March 2025. The company, incorporated in G7 with its principal executive office in Hoersholm, Denmark, is a foreign private issuer. This filing does not appear to contain specific financial updates or material events beyond the routine reporting requirement.
Why It Matters
This filing is a standard regulatory report for foreign private issuers, indicating ongoing compliance rather than new business developments.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material information that would typically impact risk.
Key Players & Entities
- Evaxion Biotech A/S (company) — Registrant
- 001-39950 (other) — Commission File Number
- 25768945 (other) — Film Number
- Dr. Neergaards Vej 5f DK-2970 Hoersholm Denmark (location) — Principal executive office address
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of March 2025.
What is Evaxion Biotech A/S's Commission File Number?
Evaxion Biotech A/S's Commission File Number is 001-39950.
Where is Evaxion Biotech A/S's principal executive office located?
Evaxion Biotech A/S's principal executive office is located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Does Evaxion Biotech A/S file annual reports under Form 20-F or 40-F?
Evaxion Biotech A/S indicates that it files annual reports under cover of Form 20-F.
What is the SIC code for Evaxion Biotech A/S?
The Standard Industrial Classification (SIC) code for Evaxion Biotech A/S is 2836, which corresponds to Biological Products (no diagnostic substances).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 25, 2025 regarding Evaxion Biotech A/S (EVAX).